Multiple Sclerosis Trial, Recruiting NCT06849882 Sponsor: Inonu University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06849882
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with multiple sclerosis (MS)
  • People who are between 18 and 65 years of age
  • People who are able to stand and balance on their own without assistance
  • People with an EDSS score of 3.5 or below (this is a scale used by doctors to measure MS-related disability — confirm with trial site)
  • People who are able to understand and follow the tests involved in the study
  • People who have completed at least a primary school level of education

Who may not be able to join:

  • People who have had an MS relapse (a flare-up of symptoms) within the last 30 days
  • People whose balance or walking difficulties are caused by a condition other than MS
  • People who are currently pregnant
  • People who have had an episode of optic neuritis (inflammation affecting vision) within the last month
  • People who are unable to complete the required tasks due to difficulties with their senses, thinking, or other related problems

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905061514082

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Inonu University
Registry
ClinicalTrials.gov
Start date
10 February 2025
Est. completion
1 March 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Dubousset Functional Testing in Individuals with MS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov